Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.
Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.